Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy

Fig. 3

Proposed decision-making algorithm of medication in primary MN patients with ACS. MN: membranous nephropathy; ACS: acute coronary syndrome; STEMI: ST-elevation myocardial infarction; NSTE: non ST-elevation; ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; PCI: percutaneous coronary intervention; AC: anticoagulation; UFH: unfractionated heparin; LRB: low risk of bleeding; HRB: high risk of bleeding; h: hours; LDL-C: low-density lipoprotein cholesterol

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us